胚胎代谢作为新型无创植入前检测:人废弃胚胎培养基的营养 turnover 与代谢组学分析
该综述检索至2024年11月,纳入49篇1989-2024年原创研究,SECM样本来自20个国家,分析能量底物、氨基酸和游离脂肪酸等单标志物(17项)及代谢组学(32项),聚焦囊胚发育、非整倍体、胚胎性别预测、着床和妊娠结局,指出培养基成分未披露等挑战,提出需统一报告指南并优先开展绝对浓度的多组学研究。
要点
- SECM代谢分析作为无创胚胎筛选标志物尚需统一报告指南和绝对浓度多组学研究。
- 49项研究中单标志物研究17项、代谢组学研究32项,多数代谢组学仅报告定性结果。
- 11家主要培养基供应商的培养基营养成分通常未披露,构成主要挑战。
核心结论
- 建立代谢组学研究的统一报告指南及SECM实验最低信息指南,可确保未来研究提供全部必要关键信息。
- 代谢组学研究主要聚焦着床和妊娠,作者首选对优质与劣质、整倍体与非整倍体胚胎代谢物绝对浓度开展多组学研究。
- 若鉴定出少量预测性生物标志物,可为每种培养基开发简单快速廉价的检测,在生殖中心临床实施。
- 未来需进一步研究基础培养基成分并结合靶向代谢组学,最终可能由人工智能整合所有主要为无创的信息、组学及其他信息。
研究设计与样本
- 综述检索截至2024年11月,检索Cochrane Library、PubMed和Google Scholar的同行评议英文人类研究,并检索相关文献的参考文献列表。
- 纳入49篇1989-2024年原创出版物,SECM样本来自20个国家。
- 17项研究聚焦能量来源(葡萄糖和丙酮酸)、氨基酸和游离脂肪酸的单标志物,32项研究进行代谢组学分析。
- 综述方案注册于OSF平台:https://osf.io/mxtbg。
主要发现
- 单标志物研究中,8项聚焦葡萄糖和丙酮酸,8项聚焦氨基酸(单独或与葡萄糖或丙酮酸联合)及其比值。
- 代谢组学研究几乎全部报告定性结果,如降低/升高或代谢物比值;对于绝对浓度,必须考虑培养基的基础浓度。
- 11家供应胚胎培养基的主要公司主导市场,其培养基营养成分通常未披露。
- 部分研究报告了某些氨基酸或葡萄糖水平的绝对量,均具有成为未来临床应用生物标志物的潜力。
临床怎么用
- 原文未据此给出推荐。
局限性
- 所有实验设计、平台和结果的差异均被分析,原文指出需要统一报告指南以确保未来研究提供全部必要关键信息。
- 培养基营养成分通常未披露构成主要挑战。
- 代谢组学研究几乎全部报告定性结果,原文指出需考虑培养基基础浓度。
- 作者提出需进一步研究基础培养基成分并结合靶向代谢组学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Single embryo transfer is globally recommended during IVF treatments. Hence, there is a growing demand for better embryo selection. Additionally, to morphology and genetics, nutrient uptake/release and metabolome profiles in spent embryo culture media (SECM) are proposed as non-invasive biomarkers. Are they ready to be applied for clinical purposes? OBJECTIVE AND RATIONALE: We reviewed methods of metabolism analysis for embryos, focusing on human SECM. SEARCH METHODS: Until November 2024, the Cochrane Library, PubMed, and Google Scholar were surfed for peer-reviewed English-language studies in the human, with MeSH terms and keywords: ART, IVF, ICSI, aneuploidy, embryo transfer, embryo selection, culture media, metabolome, metabolomics, metabolic profile, artificial intelligence (AI), nutrients, carbohydrates, glucose, pyruvate, lactate, amino acids (AAs), fatty acids (FAs), and spent embryo culture medium (SECM). Also, the reference lists of all relevant articles were searched. OUTCOMES: Forty-nine original publications (1989-2024) were found in which SECM samples were collected from 20 countries, focusing on preimplantation embryo metabolism single biomarker(s) of energy sources (glucose and pyruvate), AAs and free FAs (17 studies), or metabolomic analysis (32 studies). Focal points were blastocyst development, aneuploidy, embryo sex prediction, implantation, and pregnancy outcome. Eleven major companies, which supply embryo culture media, dominate the market. Nutrient composition of their culture media presents major challenges because they are not normally disclosed. In single-biomarker(s) studies, eight studies focus on glucose and pyruvate, eight on AAs, both alone and in combination with glucose or pyruvate, and their ratios. Since the absolute quantities of some AAs or glucose levels were reported in some studies, they all have the potential to become future biomarkers for clinical application. In metabolomics studies, almost all studies reported qualitative results, such as decrease/increase or the metabolite ratios. For absolute concentrations, the basal concentrations of the culture media must be considered. In sum, all differences in the experimental design, the platforms, and the results were analyzed. WIDER IMPLICATIONS: Establishing a unified guideline for the reporting of metabolomics studies and a specific guideline outlining the minimum information required for SECM experiment publication will ensure that future studies provide all necessary and critical information. The metabolomics studies primarily focused on implantation and pregnancy, whereas we, as a first step, preferred multi-omics studies on absolute concentrations of metabolites of good vs poor quality and euploid vs aneuploid embryos. Following this step, these quantitative approaches might lead to more convincing successes. If small numbers of predictive biomarkers were identified, a simple, rapid, and cheap test could be developed for each medium, clinically performed in the fertility center. Furthermore, further research on basal media ingredients is needed, combined with targeted metabolomics. The future could be an integration of all-primarily non-invasive-information, omics, and other, by AI. REGISTRATION NUMBER: The review protocol is registered on the OSF platform: https://osf.io/mxtbg.
引用
- Alizadeh Moghadam Masouleh A, Eftekhari-Yazdi P, Ebrahimi Sadrabadi A, et al. Embryo metabolism as a novel non-invasive preimplantation test: nutrients turn over and metabolomic analysis of human spent embryo culture media (SECM). Hum Reprod Update. 2025. PMID: 40690766. doi:10.1093/humupd/dmaf015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。